Till Bussemer;Doris Andert;Bernd Kühn;Walter KAMM;Ernst-Josef Todt
发明人:
Walter KAMM,Till Bussemer,Doris Andert,Bernd Kühn,Ernst-Josef Todt
申请号：
US13431571
公开号：
US20120252852A1
申请日:
2012.03.27
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention relates to a pharmaceutical composition comprising methyl (2R,3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino}butanoate or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable acidic reacting compound or to an aqueous solution or dispersion of the composition as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from conditions which can be ameliorated by the administration of an inhibitor of Factor Xa.
